MedPath

Evaluation of Text Message Engagement Support of Mindfulness Smartphone Applications

Not Applicable
Completed
Conditions
Anxiety
Depression
Interventions
Behavioral: Headspace - Meditation and Mindfulness App
Behavioral: Stop, Breathe, & Think - Meditation and Mindfulness App
Registration Number
NCT03633682
Lead Sponsor
Northwestern University
Brief Summary

The aim of this study is to assess the usability of two mindfulness smartphone applications (apps) and to evaluate whether text message support can promote engagement with those apps through a 4-week trial comparing support vs. no support.

Detailed Description

Part one of this study is to conduct usability testing to understand more about the acceptability and usability of these existing mindfulness apps in a population with depression and anxiety. The goal of usability testing is to identify any usability problems, provide information for future app development, and determine the participant's satisfaction with the apps. Participants will then be randomized to receive either engagement support or no support which will be delivered via text messaging, and will be randomized to use one of the two mindfulness applications for the 4 week period. Specific Aim 2.1 is to evaluate any differences on outcome measures between the two mindfulness apps. Specific Aim 2.2 is to evaluate the differences of outcome measures between text message engagement support versus no support, regardless of the mindfulness app. For Aim 2.1, the investigators predict that all mindfulness apps will be capable of leading to improvements on outcome measures. For Aim 2.2, the investigators predict that the text message engagement support arm will engage more with the mindfulness app and will see greater improvements in outcome measures regardless of the mindfulness app.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  1. meet criteria for clinically significant distress caused by anxiety defined by a Generalized Anxiety Disorder-7 (GAD-7) greater than a 10 or clinically significant distress caused my depression defined by a Patient Health Questionnaire (PHQ-9) greater than 10
  2. 18 years of age or older;
  3. fluent in English;
  4. lives in the Chicago area and are able to attend and in person session;
  5. own an internet ready smartphone with data and text plans.
Read More
Exclusion Criteria
  1. have visual, hearing, voice, or motor impairment that would prevent completion treatment procedures;
  2. past or current diagnosis of a psychotic disorder, bipolar disorder, dissociative disorder, substance or alcohol abuse dependence, or other diagnosis for which participation in the trial would be dangerous;
  3. suicidal, defined as a 1 or higher on item 9 of the Patient Health Questionnaire (PHQ-9);
  4. adults unable to consent.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Engagement SupportStop, Breathe, & Think - Meditation and Mindfulness AppIn the engagement support group, participants will be sent text messages that will encourage use of the app through tips, reminders, and encouraging messages.
Engagement SupportHeadspace - Meditation and Mindfulness AppIn the engagement support group, participants will be sent text messages that will encourage use of the app through tips, reminders, and encouraging messages.
No Engagement SupportHeadspace - Meditation and Mindfulness AppParticipants in this group will receive no text message support.
No Engagement SupportStop, Breathe, & Think - Meditation and Mindfulness AppParticipants in this group will receive no text message support.
Primary Outcome Measures
NameTimeMethod
Change in Anxiety at Week 2 and Week 4Baseline, Week 2, Week 4

Generalized Anxiety Disorder 7-item scale (GAD-7). The GAD-7 is a 7-item self-report measure of anxiety. Scores on this measure range from 0 (Not At All) to 3 (Nearly Every Day).

Change in Depression and Anxiety at Week 2 and Week 4Baseline, Week 2, Week 4

Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 is a 9-item self-report measure of depression. Scores on this measure range from 0 (Not At All) to 3 (Nearly Every Day).

Secondary Outcome Measures
NameTimeMethod
App UsageWeek 1, Week 2, Week 3, Week 4

App usage will be defined as how many minutes the participant meditated and how many meditations they listened to.

App SatisfactionWeek 1, Week 2, Week 3, Week 4

App satisfaction evaluates the participants satisfaction with the app on a scale ranging from 1 (Not At All) to 5 (Extremely).

Trial Locations

Locations (1)

Northwester University, Feinberg School of Medicine, Center for Behavioral Intervention Technologies

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath